Physician
Urology
Dr. Wm M. Linehan, MD
|
|
Give Review
Linehan practices Urology. He researched medicine at University of Oklahoma College of Medicine. He over the years received 1 awards: "Whos Who in Medicine and Healthcare". Linehan is also a published doctor. He has 60 publication published. The most recent publication is: Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
Publications
- Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
- Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease.
- Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
- Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.
- New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease.
- Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
- Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer.
- Decade in review-kidney cancer: Discoveries, therapies and opportunities.
- The somatic genomic landscape of chromophobe renal cell carcinoma.
- Nephron-sparing surgery for multifocal and hereditary renal tumors.
- Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer.
- Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
- Folliculin Controls Lung Alveolar Enlargement and Epithelial Cell Survival through E-Cadherin, LKB1, and AMPK.
- Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma.
- Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
- Intratumoral heterogeneity in kidney cancer.
- Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KI...
- Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.
- Targeted therapies: Treating advanced kidney cancer-miles to go before we sleep.
- Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathol...
- Perioperative, Functional, and Oncologic Outcomes of Partial Adrenalectomy for Multiple Ipsilateral Pheochromocytomas.
- Molecular pathways: fumarate hydratase-deficient kidney cancer--targeting the warburg effect in cancer.
- Germline PTEN Mutation Cowden Syndrome: An Under-Appreciated Form of Hereditary Kidney Cancer.
- Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement.
- Somatic Alterations Contributing to Metastasis of a Castration Resistant Prostate Cancer.
- Germline BAP1 mutation predisposes to familial clear-cell renal cell carcinoma.
- Reply to racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
- Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?
- Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation.
- Englerin A Stimulates PKC? to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality.
- The metabolic basis of kidney cancer.
- Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.
- Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
- Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma.
- Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: Feasibility, renal functional, and oncological outcomes with m...
- von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.
- Succinate dehydrogenase kidney cancer: an aggressive example of the warburg effect in cancer.
- Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
- Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.
- Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy.
- Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
- Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics.
- Economic burden of repeat renal surgery on solitary kidney-do the ends justify the means? A cost analysis.
- Correlation of magnetic resonance imaging tumor volume with histopathology.
- Adrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer.
- Inhibition of Hypoxia Inducible Factor-2 Transcription: Isolation of Active Modulators from Marine Sponges.
- Image guidance in the focal treatment of prostate cancer.
- The genetic basis of kidney cancer: implications for management and use of targeted therapeutic approaches.
- Targeting the mTOR pathway in Chromophobe Kidney Cancer.
- 11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation.
- Clinical Utility of Functional Imaging with 18F-FDOPA in Von Hippel-Lindau Syndrome.
- Comparison of 6-(18)F-Fluoro-l-DOPA, (18)F-2-deoxy-d-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
- LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.
- Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis.
- The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
- Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
- Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).
- Hereditary leiomyomatosis and renal cell carcinoma.
- Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma.
Schools
University of Oklahoma Health Sciences Center
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Duke University Hospital -
University Hospital & Clinics -
University of Oklahoma College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Carolyn A. Salter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James S. Farrell, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohummad M. Siddiqui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Su, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine L. Sears, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy F. Donahue, MD |
|
|
Dr. Lisa M. Cartwright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hernan O. Altamar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omar K. Omland, MD |
|
|
Dr. Peter A. Pinto, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|